Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6551 

SUPPLEMENTARY INFORMATION: The 

single-source award will support the 

National AIDS Control Program of Sierra 

Leone (SL) in the Ministry of Health and 

Sanitation to implement HIV strategic 

information and laboratory 

strengthening activities in SL. This 

award will build and strengthen 

laboratories that are equipped with the 

appropriate diagnostic technologies, 

trained and skilled staff, and systems 

that have the capability to provide 

efficient services. It will also strengthen 

SI systems, data quality assurance and 

capacity of staff responsible for 

managing facility-based survey and 

surveillance data operating at national 

and subnational levels. As the mandated 

institution to provide HIV treatment 

clinical services and guidelines in SL, 

the Sierra Leone Ministry of Health and 

Sanitation is in a unique position to 

conduct this work. The National HIV/ 

AIDS control program is one of the 

specialized programs within the 

Ministry of Health. 

Summary of the Award 

Recipient: Sierra Leone Ministry of 

Health and Sanitation. 

Purpose of the Award: The purpose of 

this award is to build laboratory and SI 

capacity to improve the provision of 

HIV testing, treatment, and retention in 

line with HIV epidemic control and 95– 

95–95 targets. The award will build and 

strengthen laboratories that are 

equipped with the appropriate 

diagnostic technologies, trained and 

skilled staff, and systems that have the 

capability to provide efficient services. 

Amount of Award: The approximate 

year 1 funding amount will be $450,000 

in Federal Fiscal Year (FFY) 2022 funds, 

subject to the availability of funds. 

Funding amounts for years 2–5 will be 

set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 1, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–02407 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–CE–22–013: Rigorous Evaluation 

of Community-Centered Approaches for 

the Prevention of Community Violence. 

Date: June 28–29, 2022. 

Time: 8:30 a.m.–5:30 p.m., EDT. 

Place: Videoconference. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Mikel Walters, Ph.D., Scientific Review 

Official, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–02380 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Delegation of Authority 

Notice is hereby given that the 

Director, Centers for Disease Control 

and Prevention (CDC), has delegated to 

the Chief Operating Officer, CDC, 

without the authority to redelegate, the 

authority vested in the Secretary of HHS 

by section 212(1) of the Department of 

Defense and Labor, Health and Human 

Services, and Education Appropriations 

Act, 2019 and Continuing 

Appropriations Act, 2019 (FY 19 HHS 

Appropriations Act) Public Law 115– 

245, division B, title II, or substantially 

similar authorities vested in the 

Secretary in the future by Congress, in 

order to carry out international health 

activities. 

Section 212(1) of the FY19 HHS 

Appropriations Act permits the 

Secretary of HHS to exercise authority 

equivalent to that available to the 

Secretary of State under 22 U.S.C 

2669(c) to award personal services 

contracts for work performed in foreign 

countries. The authority delegated 

herein includes the authority to 

determine the necessity of negotiating, 

executing, and performing such 

contracts without regard to statutory 

provisions as related to the negotiation, 

making, and performance of contracts 

and performance of work in the United 

States. 

The authority under section 212(1) is 

immediately revoked in the event that 

any subsequent fiscal year HHS 

appropriations act does not contain the 

provision currently in section 212(1) or 

substantially similar authority. 

The Chief Operating Officer, CDC, 

shall consult with the Secretary of State 

and relevant Chief of Mission to ensure 

that this authority is exercised in a 

manner consistent with section 207 of 

the Foreign Service Act of 1980 and 

other applicable statutes administered 

by the Department of State. 

This delegation supersedes the 

delegation of similar name, approved by 

the Director, CDC, on March 17, 2020. 

This delegation became effective on 

January 31, 2022. The Director, CDC, 

affirms and ratifies any actions taken 

that involve the exercise of the authority 

delegated herein prior to the effective 

date of this delegation. 

Sherri A. Berger, 

Chief of Staff, Centers for Disease Control 

and Prevention. 

[FR Doc. 2022–02328 Filed 2–3–22; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1